CliffBio
small molecule

DUAVEE

BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED

Loss of exclusivityMarch 2027latest FDA-listed patent expiry
CompanyWyeth →See this company's full patent-cliff portfolio

Drug detail

Brand nameDUAVEE
Active ingredientBAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED
StrengthEQ 20MG BASE;0.45MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2013
Marketing statusRX

Listed patents

PatentExpiresType
7683051March 2027substance, product

More from Wyeth

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.